| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | America Movil stock rating resumed at Neutral by BofA Securities | ||
| Do | Aardvark Therapeutics stock rises 13% on positive trial updates, BTIG maintains Buy | ||
| Do | AeroVironment stock price target lowered to $390 from $415 at Jefferies | ||
| Do | Ciena stock price target raised to $240 from $200 at Evercore ISI | ||
| Do | SITE Centers sells Downtown Short Pump property for $31.5 million | ||
| Do | Structure Therapeutics closes $747.5 million public offering | ||
| Do | Dynex Capital declares $0.17 per share dividend for December 2025 | ||
| Do | Oruka Therapeutics appoints Chris Martin to board of directors | ||
| Do | Salesforce Q3 FY26 slides: revenue grows 9% as capital returns accelerate | ||
| Do | Barings Participation Investors declares $0.37 quarterly dividend | ||
| Do | Barings Corporate Investors declares $0.40 quarterly dividend | ||
| Do | Gold Strategy closes private placement raising $293,906 | ||
| Do | Ciena price target raised to $270 from $230 at Stifel on AI demand | ||
| Do | Uber adds regional grocery and alcohol retailers to delivery apps | ||
| Do | AlphaTON Capital signs 2.2 MW data center agreement with atNorth | ||
| Do | Kartoon Studios and AETH team up to launch live-action venture | ||
| Do | Rhythm Pharmaceuticals stock holds Buy rating at TD Cowen on PWS trial data | ||
| Do | Raymond James raises Electrovaya stock price target to $9.50 from $6.00 | ||
| Do | ALLETE acquisition by CPP Investments and GIP set to close Dec 15 | ||
| Do | Gedatolisib shows promising results in breast cancer trial | ||
| Do | Ciena stock price target raised to $250 from $120 at Raymond James | ||
| Do | DA Davidson lowers Lovesac stock price target to $18 on delayed product launch | ||
| Do | T1 Energy stock maintains Buy rating at Needham with $6.00 price target | ||
| Do | Smolyansky urges Lifeway shareholders to vote for board changes | ||
| Do | L3Harris demonstrates cross-agency communication capabilities |